Suresh K. Durgam - Mar 6, 2025 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
EVP, Chief Medical Officer
Signature
/s/ John P. Condon, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Mar 6, 2025
Transactions value $
-$1,139,935
Form type
4
Date filed
3/10/2025, 06:01 PM
Previous filing
Mar 4, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +13.1K +42.2% 44.3K Mar 6, 2025 Direct F1
transaction ITCI Common Stock Tax liability -$731K -5.57K -12.59% $131.19 38.7K Mar 6, 2025 Direct F2
transaction ITCI Common Stock Options Exercise +7.35K +18.99% 46K Mar 10, 2025 Direct F1
transaction ITCI Common Stock Tax liability -$409K -3.12K -6.77% $131.24 42.9K Mar 10, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -13.1K -50% $0.00 13.1K Mar 6, 2025 Common Stock 13.1K Direct F3, F4
transaction ITCI Restricted Stock Units Options Exercise $0 -7.35K -100% $0.00 0 Mar 10, 2025 Common Stock 7.35K Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the reporting person.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 On March 6, 2023, the reporting person was granted 39,398 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F5 On March 10, 2022, the reporting person was granted 22,034 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.